• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The role of EMMPRIN in T cell biology and immunological diseases.EMMPRIN在T细胞生物学及免疫性疾病中的作用
J Leukoc Biol. 2015 Jul;98(1):33-48. doi: 10.1189/jlb.3RU0215-045R. Epub 2015 May 14.
2
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.一种新型抗 EMMPRIN 功能阻断抗体可减少 T 细胞增殖和神经毒性:与多发性硬化症相关。
J Neuroinflammation. 2012 Apr 5;9:64. doi: 10.1186/1742-2094-9-64.
3
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.米诺环素对细胞外基质金属蛋白酶诱导剂的影响,细胞外基质金属蛋白酶诱导剂是一种与多发性硬化免疫发病机制相关的因子。
J Immunol. 2016 Nov 15;197(10):3850-3860. doi: 10.4049/jimmunol.1600436. Epub 2016 Oct 12.
4
CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.肾脏疾病中的CD147(细胞外基质金属蛋白酶诱导因子/基底膜蛋白):从炎症和免疫系统角度分析
Nephrol Dial Transplant. 2015 Jul;30(7):1097-103. doi: 10.1093/ndt/gfu302. Epub 2014 Sep 23.
5
EMMPRIN, an upstream regulator of MMPs, in CNS biology.EMMPRIN,MMPs 的上游调节因子,在中枢神经系统生物学中。
Matrix Biol. 2015 May-Jul;44-46:138-46. doi: 10.1016/j.matbio.2015.01.018. Epub 2015 Jan 31.
6
Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.细胞外基质金属蛋白酶诱导因子 EMMPRIN(CD147)与心血管疾病。
Int J Mol Sci. 2018 Feb 8;19(2):507. doi: 10.3390/ijms19020507.
7
Crosstalk Between Human Monocytic U937 Cells and Gingival Fibroblasts in Coculturally Enhanced Matrix Metalloproteinase-2 Expression.人单核细胞U937细胞与牙龈成纤维细胞在共培养中增强基质金属蛋白酶-2表达的细胞间相互作用
J Periodontol. 2016 Oct;87(10):1228-37. doi: 10.1902/jop.2016.140653. Epub 2016 Jun 13.
8
CD147: a novel modulator of inflammatory and immune disorders.CD147:一种新型炎症和免疫紊乱调节剂。
Curr Med Chem. 2014;21(19):2138-45. doi: 10.2174/0929867321666131227163352.
9
EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction.细胞外基质金属蛋白酶诱导因子(CD147)是血小板糖蛋白VI(GPVI)的一种新型受体,并通过GPVI-细胞外基质金属蛋白酶诱导因子相互作用介导血小板滚动。
Thromb Haemost. 2009 Apr;101(4):682-6. doi: 10.1160/th08-06-0368.
10
Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts.可溶性细胞外基质金属蛋白酶诱导因子(EMMPRIN)刺激人喉癌细胞系HEp-2的迁移,同时伴随着成纤维细胞中MMP-2生成增加。
Arch Histol Cytol. 2007 Dec;70(5):267-77. doi: 10.1679/aohc.70.267.

引用本文的文献

1
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria.用于治疗药物脑递送的受体介导转胞吞作用:受体类别与标准
Front Drug Deliv. 2024 Mar 12;4:1360302. doi: 10.3389/fddev.2024.1360302. eCollection 2024.
2
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside.嵌合抗原受体自然杀伤细胞治疗胃肠道肿瘤免疫治疗:从基础到临床。
Mol Cancer. 2024 Oct 23;23(1):237. doi: 10.1186/s12943-024-02151-3.
3
CAR-T cell therapy: Advances in digestive system malignant tumors.嵌合抗原受体T细胞疗法:消化系统恶性肿瘤的研究进展
Mol Ther Oncol. 2024 Sep 10;32(4):200872. doi: 10.1016/j.omton.2024.200872. eCollection 2024 Dec 19.
4
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers.工程化 CD147-CAR 巨噬细胞增强对癌症的吞噬作用。
Cancer Immunol Immunother. 2024 Jul 2;73(9):170. doi: 10.1007/s00262-024-03759-6.
5
Embigin deficiency leads to delayed embryonic lung development and high neonatal mortality in mice.在小鼠中,Embigin缺乏会导致胚胎肺发育延迟和新生儿死亡率升高。
iScience. 2024 Jan 15;27(2):108914. doi: 10.1016/j.isci.2024.108914. eCollection 2024 Feb 16.
6
CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.CD147/Basigin 通过调节糖酵解参与恶性肿瘤的发生和 T 细胞介导的免疫紊乱。
Int J Mol Sci. 2023 Dec 11;24(24):17344. doi: 10.3390/ijms242417344.
7
Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.构建和验证用于肝细胞癌预后、诊断和治疗决策的新型溶酶体特征。
Sci Rep. 2023 Dec 18;13(1):22624. doi: 10.1038/s41598-023-49985-3.
8
I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies.I 标记的抗 CD147 抗体用于非侵入性检测 CD147 阳性的泛癌:构建和临床前研究。
Acta Pharmacol Sin. 2024 Feb;45(2):436-448. doi: 10.1038/s41401-023-01162-y. Epub 2023 Sep 25.
9
Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma.分化簇147的表达模式影响肝细胞癌的预后。
World J Gastrointest Oncol. 2023 Aug 15;15(8):1412-1423. doi: 10.4251/wjgo.v15.i8.1412.
10
Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis.CD147 抑制剂抑制柯萨奇病毒 B3 诱导的急性病毒性心肌炎中的 T 细胞活化和募集。
Viruses. 2023 May 10;15(5):1137. doi: 10.3390/v15051137.

本文引用的文献

1
Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN.肿瘤衍生的微泡通过差异糖基化的胞外基质金属蛋白酶诱导因子介导人类乳腺癌侵袭。
J Mol Cell Biol. 2015 Apr;7(2):143-53. doi: 10.1093/jmcb/mju047. Epub 2014 Dec 11.
2
The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.CD147在人类疾病中的生物学功能及临床应用:当前科学文献综述
Int J Mol Sci. 2014 Sep 29;15(10):17411-41. doi: 10.3390/ijms151017411.
3
CD147 and CD98 complex-mediated homotypic aggregation attenuates the CypA-induced chemotactic effect on Jurkat T cells.CD147与CD98复合物介导的同型聚集减弱了环孢素A对Jurkat T细胞的趋化作用。
Mol Immunol. 2015 Feb;63(2):253-63. doi: 10.1016/j.molimm.2014.07.005. Epub 2014 Aug 1.
4
Enhancement of CD147 on M1 macrophages induces differentiation of Th17 cells in the lung interstitial fibrosis.M1巨噬细胞上CD147的增强诱导肺间质纤维化中Th17细胞的分化。
Biochim Biophys Acta. 2014 Sep;1842(9):1770-82. doi: 10.1016/j.bbadis.2014.06.008. Epub 2014 Jun 14.
5
Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization.致病性脑膜炎奈瑟菌利用 CD147 进行血管定植。
Nat Med. 2014 Jul;20(7):725-31. doi: 10.1038/nm.3563. Epub 2014 Jun 1.
6
The pathology of T cells in systemic lupus erythematosus.系统性红斑狼疮中 T 细胞的病理学。
J Immunol Res. 2014;2014:419029. doi: 10.1155/2014/419029. Epub 2014 Apr 23.
7
Importance of N-glycosylation on CD147 for its biological functions.N-糖基化对CD147生物学功能的重要性。
Int J Mol Sci. 2014 Apr 15;15(4):6356-77. doi: 10.3390/ijms15046356.
8
Plasma CD147 reflects histological features in patients with lupus nephritis.血浆 CD147 反映狼疮肾炎患者的组织学特征。
Lupus. 2014 Apr;23(4):342-52. doi: 10.1177/0961203314520840. Epub 2014 Jan 28.
9
Important functional roles of basigin in thymocyte development and T cell activation.Basigin 在胸腺细胞发育和 T 细胞激活中的重要功能作用。
Int J Biol Sci. 2013 Dec 13;10(1):43-52. doi: 10.7150/ijbs.6818. eCollection 2013.
10
Acute graft-versus-host disease: are we close to bringing the bench to the bedside?急性移植物抗宿主病:我们是否即将实现从基础到临床的转化?
Best Pract Res Clin Haematol. 2013 Sep;26(3):285-92. doi: 10.1016/j.beha.2013.10.009. Epub 2013 Oct 16.

EMMPRIN在T细胞生物学及免疫性疾病中的作用

The role of EMMPRIN in T cell biology and immunological diseases.

作者信息

Hahn Jennifer Nancy, Kaushik Deepak Kumar, Yong V Wee

机构信息

Hotchkiss Brain Institute, University of Calgary, Alberta, Canada.

Hotchkiss Brain Institute, University of Calgary, Alberta, Canada

出版信息

J Leukoc Biol. 2015 Jul;98(1):33-48. doi: 10.1189/jlb.3RU0215-045R. Epub 2015 May 14.

DOI:10.1189/jlb.3RU0215-045R
PMID:25977287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7166407/
Abstract

EMMPRIN (CD147), originally described as an inducer of the expression of MMPs, has gained attention in its involvement in various immunologic diseases, such that anti-EMMPRIN antibodies are considered as potential therapeutic medications. Given that MMPs are involved in the pathogenesis of various disease states, it is relevant that targeting an upstream inducer would make for an effective therapeutic strategy. Additionally, EMMPRIN is now appreciated to have multiple roles apart from MMP induction, including in cellular functions, such as migration, adhesion, invasion, energy metabolism, as well as T cell activation and proliferation. Here, we review what is known about EMMPRIN in numerous immunologic/inflammatory disease conditions with a particular focus on its complex roles in T cell biology.

摘要

细胞外基质金属蛋白酶诱导因子(EMMPRIN,CD147)最初被描述为基质金属蛋白酶(MMPs)表达的诱导剂,因其参与多种免疫疾病而受到关注,因此抗EMMPRIN抗体被视为潜在的治疗药物。鉴于MMPs参与多种疾病状态的发病机制,靶向其上游诱导剂可能是一种有效的治疗策略。此外,现在人们认识到EMMPRIN除了诱导MMPs外还具有多种作用,包括在细胞功能方面,如迁移、黏附、侵袭、能量代谢,以及T细胞活化和增殖。在此,我们综述了关于EMMPRIN在众多免疫/炎症疾病中的已知情况,特别关注其在T细胞生物学中的复杂作用。